Search Results

There are 24962 results for: content related to: Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial


    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  3. You have free access to this content
    AASLD Abstracts


    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 28–38, Lenna A. Martyak, Ehsan Taqavi and Sammy Saab

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01618.x

  5. You have free access to this content
    Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 7, October 2006, Pages: 1003–1016, H. E. KOHRT, D. L. OUYANG and E. B. KEEFFE

    Version of Record online : 12 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03081.x

  6. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  7. You have free access to this content
    Chronic hepatitis B


    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  8. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

    Journal of Medical Virology

    Volume 59, Issue 3, November 1999, Pages: 263–269, Winnie Yeo, Joyce L. Steinberg, John S. Tam, Paul K.S. Chan, Nancy W.Y. Leung, Kwok C. Lam, Tony S.K. Mok and Philip J. Johnson

    Version of Record online : 27 SEP 1999, DOI: 10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X

  9. Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation

    Hematological Oncology

    Volume 34, Issue 3, September 2016, Pages: 140–146, Alok Gupta, Sachin Punatar, Jayant Gawande, Bhausaheb Bagal, Libin Mathew, Vivek Bhat, Sadhana Kannan and Navin Khattry

    Version of Record online : 18 FEB 2015, DOI: 10.1002/hon.2195

  10. You have free access to this content
    Abstracts 890 to 1096


    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  11. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 141–147, R. Idilman, M. Arat, E. Soydan, M. Törüner, İ. Soykan, H. Akbulut, Ö. Arslan, M. Özcan, A. R. Türkyilmaz, M. Bozdayı, S. Karayalçın, D. H. Van Thiel, A. Özden, M. Beksaç and H. Akan

    Version of Record online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00479.x

  12. You have free access to this content
    Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant–associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin

    Liver Transplantation and Surgery

    Volume 5, Issue 6, November 1999, Pages: 512–519, Geoffrey W. McCaughan, Jenean Spencer, David Koorey, Scott Bowden, Angeline Bartholomeusz, Margaret Littlejohn, Deborah Verran, Albert K.K. Chui, A.G. Ross Sheil, Robert M. Jones, Stephen A. Locarnini and Peter W. Angus

    Version of Record online : 30 DEC 2003, DOI: 10.1002/lt.500050601

  13. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience

    Pediatric Transplantation

    Volume 13, Issue 7, November 2009, Pages: 923–926, M. Faraci, B. Cappelli, E. Lanino, G. Morreale, F. Fioredda, C. L. Giudice and R. Giacchino

    Version of Record online : 19 NOV 2008, DOI: 10.1111/j.1399-3046.2008.01080.x

  14. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 540–546, M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu and T. Y. Chao

    Version of Record online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0964.x

  15. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

    Liver International

    Volume 33, Issue 8, September 2013, Pages: 1203–1210, Fei W. Chen, Luke Coyle, Brett E. Jones and Venessa Pattullo

    Version of Record online : 24 MAR 2013, DOI: 10.1111/liv.12154

  16. You have free access to this content
    Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

    American Journal of Hematology

    Volume 80, Issue 3, November 2005, Pages: 197–203, Themistoklis Vassiliadis, Vassilia Garipidou, Konstantinos Tziomalos, Vassilios Perifanis, Olga Giouleme and Sofia Vakalopoulou

    Version of Record online : 24 OCT 2005, DOI: 10.1002/ajh.20471

  17. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  18. You have free access to this content
    Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 864–871, John S Lubel and Peter W Angus

    Version of Record online : 28 APR 2010, DOI: 10.1111/j.1440-1746.2010.06243.x

  19. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  20. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis

    Journal of Viral Hepatitis

    Volume 15, Issue 2, February 2008, Pages: 89–102, L. H. Katz, A. Fraser, A. Gafter-Gvili, L. Leibovici and R. Tur-Kaspa

    Version of Record online : 24 SEP 2007, DOI: 10.1111/j.1365-2893.2007.00902.x